Does ATORVASTATIN Cause Hepatocellular injury? 610 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 610 reports of Hepatocellular injury have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.8% of all adverse event reports for ATORVASTATIN.
610
Reports of Hepatocellular injury with ATORVASTATIN
0.8%
of all ATORVASTATIN reports
37
Deaths
415
Hospitalizations
How Dangerous Is Hepatocellular injury From ATORVASTATIN?
Of the 610 reports, 37 (6.1%) resulted in death, 415 (68.0%) required hospitalization, and 56 (9.2%) were considered life-threatening.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 610 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
METHYLPREDNISOLONE (300)
Which ATORVASTATIN Alternatives Have Lower Hepatocellular injury Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM